Want to see DHR full AI Analyst Report?

Danaher (DHR) Stock Forecast & Price Target

3,315 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

DHR Analyst Ratings

Strong Buy

17 Buy

3 Hold

0 Sell

Based on 20 analysts giving stock ratings to

Danaher

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

DHR Stock 12 Month Forecast

Average Price Target

$219.78

▲(14.77% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is $219.78 with a high forecast of $240.00 and a low forecast of $195.00. The average price target represents a 14.77% change from the last price of $191.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"173":"$173","190":"$190","207":"$207","224":"$224","241":"$241"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":240,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$240.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":219.77777777777774,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$219.78</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":195,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$195.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[173,190,207,224,241],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,194.98,198.44307692307692,201.90615384615384,205.36923076923077,208.8323076923077,212.29538461538462,215.75846153846152,219.22153846153844,222.68461538461537,226.1476923076923,229.61076923076922,233.07384615384615,236.53692307692307,{"y":240,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,194.98,196.88752136752134,198.79504273504273,200.70256410256408,202.61008547008547,204.51760683760682,206.42512820512817,208.33264957264956,210.2401709401709,212.1476923076923,214.05521367521365,215.962735042735,217.8702564102564,{"y":219.77777777777774,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,194.98,194.98153846153846,194.9830769230769,194.98461538461538,194.98615384615383,194.9876923076923,194.98923076923077,194.99076923076922,194.9923076923077,194.99384615384616,194.9953846153846,194.99692307692308,194.99846153846153,{"y":195,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":195.646,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":204.312,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":211.694,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":214.18,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":222.891,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":227.96,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":222.483,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":205.136,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.395,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.787,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":179.497,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":193.72,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.98,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$240.00

Average Price Target$219.78

Lowest Price Target$195.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Luke Sergott

Barclays

$230

Buy

20.10%

Upside

Reiterated

08/04/26

Danaher (DHR) Gets a Buy from Barclays

Michael Ryskin

Bank of America Securities

$230

Buy

20.10%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK), Rocket Pharmaceuticals (NASDAQ: RCKT) and Danaher (NYSE: DHR)

Kallum Titchmarsh

Morgan Stanley

$220

Buy

14.88%

Upside

Reiterated

08/03/26

Analysts' Top Healthcare Picks: Danaher (DHR), Vertex Pharmaceuticals (VRTX)

Evie Koslosky

Goldman Sachs

$210

Buy

9.66%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Danaher (NYSE: DHR) and Henry Schein (NASDAQ: HSIC)

David Westenberg

Piper Sandler

$200

Hold

4.44%

Upside

Reiterated

07/27/26

Piper Sandler Sticks to Its Hold Rating for Danaher (DHR)

Tycho Peterson

Jefferies

$210

Buy

9.66%

Upside

Reiterated

07/27/26

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (NASDAQ: RARE) and Danaher (NYSE: DHR)

David Toung

Argus Research

$230

Buy

20.10%

Upside

Assigned

07/23/26

Danaher's recent volatility presents buying opportunity, says ArgusDanaher's recent volatility presents buying opportunity, says Argus

Casey Woodring

J.P. Morgan

$245→$220

Buy

14.88%

Upside

Reiterated

07/23/26

J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)

Brandon Couillard

Wells Fargo

$212→$195

Hold

1.83%

Upside

Reiterated

07/22/26

Wells Fargo Remains a Hold on Danaher (DHR)

Daniel Brennan

TD Cowen

$240→$236

Buy

23.24%

Upside

Reiterated

07/22/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF), Danaher (NYSE: DHR) and TransMedics Group (NASDAQ: TMDX)

Matt Larew

William Blair

―

Buy

―

Reiterated

07/22/26

Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Illumina (ILMN)

Daniel Arias

Stifel Nicolaus

$260→$220

Buy

14.88%

Upside

Reiterated

07/22/26

Danaher price target lowered to $220 from $260 at StifelDanaher price target lowered to $220 from $260 at Stifel

Patrick B Donnelly

Citi

$230

Buy

20.10%

Upside

Reiterated

07/22/26

Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230

Justin Bowers

Deutsche Bank

$250→$240

Buy

25.33%

Upside

Assigned

07/22/26

Danaher price target lowered to $240 from $250 at Deutsche BankDanaher price target lowered to $240 from $250 at Deutsche Bank

Subbu Nambi

Guggenheim

$235→$200

Buy

4.44%

Upside

Reiterated

07/21/26

Danaher price target lowered to $200 from $235 at GuggenheimDanaher price target lowered to $200 from $235 at Guggenheim

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Luke Sergott

Barclays

$230

Buy

20.10%

Upside

Reiterated

08/04/26

Danaher (DHR) Gets a Buy from Barclays

Michael Ryskin

Bank of America Securities

$230

Buy

20.10%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK), Rocket Pharmaceuticals (NASDAQ: RCKT) and Danaher (NYSE: DHR)

Kallum Titchmarsh

Morgan Stanley

$220

Buy

14.88%

Upside

Reiterated

08/03/26

Analysts' Top Healthcare Picks: Danaher (DHR), Vertex Pharmaceuticals (VRTX)

Evie Koslosky

Goldman Sachs

$210

Buy

9.66%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Danaher (NYSE: DHR) and Henry Schein (NASDAQ: HSIC)

David Westenberg

Piper Sandler

$200

Hold

4.44%

Upside

Reiterated

07/27/26

Piper Sandler Sticks to Its Hold Rating for Danaher (DHR)

Tycho Peterson

Jefferies

$210

Buy

9.66%

Upside

Reiterated

07/27/26

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (NASDAQ: RARE) and Danaher (NYSE: DHR)

David Toung

Argus Research

$230

Buy

20.10%

Upside

Assigned

07/23/26

Danaher's recent volatility presents buying opportunity, says ArgusDanaher's recent volatility presents buying opportunity, says Argus

Casey Woodring

J.P. Morgan

$245→$220

Buy

14.88%

Upside

Reiterated

07/23/26

J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)

Brandon Couillard

Wells Fargo

$212→$195

Hold

1.83%

Upside

Reiterated

07/22/26

Wells Fargo Remains a Hold on Danaher (DHR)

Daniel Brennan

TD Cowen

$240→$236

Buy

23.24%

Upside

Reiterated

07/22/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF), Danaher (NYSE: DHR) and TransMedics Group (NASDAQ: TMDX)

Matt Larew

William Blair

―

Buy

―

Reiterated

07/22/26

Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Illumina (ILMN)

Daniel Arias

Stifel Nicolaus

$260→$220

Buy

14.88%

Upside

Reiterated

07/22/26

Danaher price target lowered to $220 from $260 at StifelDanaher price target lowered to $220 from $260 at Stifel

Patrick B Donnelly

Citi

$230

Buy

20.10%

Upside

Reiterated

07/22/26

Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230

Justin Bowers

Deutsche Bank

$250→$240

Buy

25.33%

Upside

Assigned

07/22/26

Danaher price target lowered to $240 from $250 at Deutsche BankDanaher price target lowered to $240 from $250 at Deutsche Bank

Subbu Nambi

Guggenheim

$235→$200

Buy

4.44%

Upside

Reiterated

07/21/26

Danaher price target lowered to $200 from $235 at GuggenheimDanaher price target lowered to $200 from $235 at Guggenheim

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

ZURAZura Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Danaher

3 Months

Dan LeonardRBC Capital

Success Rate

16/21 ratings generated profit

Average Return

+9.25%

Copying Dan Leonard's trades and holding each position for 3 Months would result in 76.19% of your transactions generating a profit, with an average return of +9.25% per trade.

1 Year

Dan LeonardRBC Capital

Success Rate

15/21 ratings generated profit

Average Return

+22.53%

Copying Dan Leonard's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +22.53% per trade.

2 Years

Dan LeonardRBC Capital

Success Rate

16/21 ratings generated profit

Average Return

+38.92%

Copying Dan Leonard's trades and holding each position for 2 Years would result in 76.19% of your transactions generating a profit, with an average return of +38.92% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DHR Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, DHR has received 27 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. DHR average Analyst price target in the past 3 months is 219.78.

Each month's total comprises the sum of three months' worth of ratings.

DHR Financial Forecast

DHR Earnings Forecast

Next quarter’s earnings estimate for DHR is $1.93 with a range of $1.89 to $2.05. The previous quarter’s EPS was $1.94. DHR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 36.78% of the time in the same period. In the last calendar year DHR has Performed in-line its overall industry.

DHR Sales Forecast

Next quarter’s sales forecast for DHR is $6.53B with a range of $6.24B to $6.67B. The previous quarter’s sales results were $6.26B. DHR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.91% of the time in the same period. In the last calendar year DHR has Performed in-line its overall industry.

DHR Stock Forecast FAQ

What is DHR’s average 12-month price target, according to analysts?

Based on analyst ratings, Danaher Corporation’s 12-month average price target is 219.78.

What is DHR’s upside potential, based on the analysts’ average price target?

Danaher Corporation has 14.77% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is DHR a Buy, Sell or Hold?

Danaher Corporation has a consensus rating of Strong Buy which is based on 17 buy ratings, 3 hold ratings and 0 sell ratings.

What is Danaher Corporation’s price target?

The average price target for Danaher Corporation is 219.78. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $240.00 ,the lowest forecast is $195.00. The average price target represents 14.77% Increase from the current price of $191.5.

What do analysts say about Danaher Corporation?

Danaher Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of DHR?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Danaher (DHR) Stock Forecast & Price Target

DHR Analyst Ratings

DHR Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Danaher

DHR Analyst Recommendation Trends

DHR Financial Forecast

DHR Earnings Forecast

DHR Sales Forecast

DHR Stock Forecast FAQ

Detailed List of Analyst Forecasts